RT @BMC_series: Cancer therapy: new #BMCCancer study shows addition of small molecule proteasome inhibitor #ixazomib to lenalidomide and de…
1,331 followers
6,237 followers
RT @BMC_series: Cancer therapy: new #BMCCancer study shows addition of small molecule proteasome inhibitor #ixazomib to lenalidomide and de…
21,593 followers
Cancer therapy: new #BMCCancer study shows addition of small molecule proteasome inhibitor #ixazomib to lenalidomide and dexamethasone improves key survival endpoints in relapsed and refractory multiple #myeloma patients 👉 https://t.co/xLgaU32vW2 @UPOlomou
925 followers
New article: Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice. https://t.co/BkKxEIJpFP #MMSM #MultipleMyeloma #hema